POU2AF1

Across TCGA pan-cancer cohorts, POU2AF1 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated POU2AF1 data layer compared with 25 for mass-spec protein and 6 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher POU2AF1 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated POU2AF1 expression acts as an unfavorable survival marker, although some lineages such as LUAD and PDAC show a favorable association.

LUAD and PDAC are the cancer types where POU2AF1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Median	II,III,IV	0.881	0.344	.005	16	view →
PDAC	DFS	Median	II,III,IV	0.858	0.461	.047	3	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

POU2AF1–LUAD (DFS)

Open the LUAD breakdown →